Top Healthcare Stocks
Healthcare stocks are narrowly mixed in late trade with the NYSE
Healthcare Sector Index adding less than 0.1% with shares of
healthcare companies in the S&P 500 down 0.1% as a group.
In company news, LipoScience (
) is down nearly 11% shortly before the close at $5.74 a share
after the in-vitro diagnostics company issuing downside revenue
guidance for the three months that ended in June as well as
lowering its FY13 outlook.
LPDX now sees Q2 revenue of around $13.3 million, near the
bottom of its prior guidance for the quarter and trailing the
consensus analyst call looking for $13.74 million in Q2 revenue. It
also cut its forecast for FY13 revenue by $2 million from its
previous outlook, now guiding for $52 million to $54 million in
sales this year.
Analysts, on average, are expecting LPDX to generate around
$55.37 million in FY13 revenue.
The company today also said that Richard Brajer has stepped down
as president and CEO to pursue other interests with board member
Robert Greczyn taking the posts on an interim basis. The LPDX board
plans to begin a search for a permanent CEO immediately.
In other sector news,
(+) UPI, Medicare administrative contractor Novitas Solutions
expands coverage for posterior tibial nerve stimulation using UPI's
Urgent PC neuromodulation system to treat overactive bladder and
(-) ONVO, Prices offering of 9 million shares of its common
stock at $4.50 apiece, generating $40.5 million in gross